Is there a role for adjuvant treatment in patients with T3N0M0 breast cancer treated by modified radical mastectomy?

被引：0
|
作者：
Hayes, MK
Ravi, A
Antonacci, R
Schiff, PB
机构：
来源：
RADIOLOGY | 1997年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [41] Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer
    Meric, F
    Mirza, NQ
    Buzdar, AU
    Hunt, KK
    Ames, FC
    Ross, MI
    Pollock, RE
    Newman, LA
    Feig, BW
    Strom, EA
    Buchholz, TA
    McNeese, MD
    Hortobagyi, GN
    Singletary, SE
    ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (06) : 435 - 440
  • [42] Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?
    Lee, Kyung-Goo
    Lee, Hyuk-Joon
    Oh, Seung-Young
    Yang, Jun-Young
    Ahn, Hye-Seong
    Suh, Yun-Suhk
    Kong, Seong-Ho
    Kim, Tae-Yong
    Oh, Do-Youn
    Im, Seock-Ah
    Lee, Kuhn Uk
    Kim, Woo Ho
    Bang, Yung-Jue
    Yang, Han-Kwang
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (04) : 1234 - 1243
  • [43] ASO Author Reflections: Refining Radiotherapy Decisions in T3N0M0 Breast Cancer: A Nomogram-Based Approach
    Xiangdi Meng
    Nan Wang
    Peiyan Qin
    Qingyu Jia
    Zhuojun Ju
    Yingxiao Jiang
    Annals of Surgical Oncology, 2024, 31 : 2274 - 2275
  • [44] Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms
    Ohmori, Yukimi
    Nomura, Takashi
    Fukushima, Norimasa
    Takahashi, Fumiaki
    Iwaya, Takeshi
    Koeda, Keisuke
    Nishizuka, Satoshi S.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1154 - 1161
  • [45] ASO Author Reflections: Refining Radiotherapy Decisions in T3N0M0 Breast Cancer: A Nomogram-Based Approach
    Meng, Xiangdi
    Wang, Nan
    Qin, Peiyan
    Jia, Qingyu
    Ju, Zhuojun
    Jiang, Yingxiao
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2274 - 2275
  • [46] Outcomes of Mastectomy With and Without Adjuvant Radiation for T1-2N0M0 Triple Negative Breast Cancer: SEER Analysis
    Szeja, S.
    Hatch, S. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E30 - E31
  • [47] Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx Reply
    Witek, Matthew E.
    Hartig, Gregory K.
    Harari, Paul M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 144 (06) : 543 - 543
  • [48] T3N0M0 NSCLC Subtypes - A Signal for Disparate Outcomes after Surgery
    Ferrari-Light, Dana
    Kneuertz, Peter J.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2023, 35 (04) : 805 - 806
  • [49] Post-mastectomy radiotherapy in pT3N0M0 breast cancer:: is it needed?
    Helintö, M
    Blomqvist, C
    Heikkilä, P
    Joensuu, H
    RADIOTHERAPY AND ONCOLOGY, 1999, 52 (03) : 213 - 217
  • [50] TREATMENT OF EARLY CANCER OF THE BREAST (T1N0M0 AND T2N0M0) ON THE BASIS OF HISTOLOGIC CHARACTERISTICS
    NEALON, TF
    NKONGHO, A
    GROSSI, CE
    WARD, R
    NEALON, C
    GILLOOLEY, JF
    SURGERY, 1981, 89 (03) : 279 - 289
12345